NexGel Inc

Last updated September 27, 2026

Organization details

Legal name
NexGel Inc
Former names
AquaMed Technologies, Inc.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
3841 — Surgical & Medical Instruments & Apparatus
Jurisdiction of incorporation
Delaware
Headquarters city
Langhorne
Headquarters state / province
Pennsylvania
Headquarters country
United States
Fiscal year end
December
Ticker symbol
NXGL
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001468929
EIN
26-4042544

Board of directors

Chief executives

Adam R. Levy · Chief Executive Officer
Dates unknown

Director election results

Annual meeting of July 31, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

2 of this board's directors also sit on 4 other boards. 4 are in the same sector.

Network of NexGel Inc's board connections Entera Bio Ltd. Entera Bio Ltd. Journey Medical Corporation Journey Medical Corpor... PTC Therapeutics Inc. PTC Therapeutics Inc. Soligenix Inc. Soligenix Inc. Jerome B. Zeldis Jerome B. Zeldis Miranda Jayne Toledano Miranda Jayne Toleda... NexGel Inc
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$36,730
11 sales by 1 insider
Date Insider Transaction Shares Price Value
Jun 23, 2026 Adam R. Levy Director, Officer (Chief Executive Officer) Open-market sale −5,000 $0.59 $2,950
Jun 18, 2026 Adam R. Levy Director, Officer (Chief Executive Officer) Open-market sale −6,000 $0.59 $3,540
Jun 11, 2026 Adam R. Levy Director, Officer (Chief Executive Officer) Open-market sale −3,000 $0.61 $1,830
Jun 8, 2026 Adam R. Levy Director, Officer (Chief Executive Officer) Open-market sale −3,000 $0.55 $1,650
Jun 4, 2026 Adam R. Levy Director, Officer (Chief Executive Officer) Open-market sale −3,000 $0.59 $1,770
Jun 1, 2026 Adam R. Levy Director, Officer (Chief Executive Officer) Open-market sale −2,000 $0.59 $1,180
May 29, 2026 Adam R. Levy Director, Officer (Chief Executive Officer) Open-market sale −3,000 $0.60 $1,800
May 28, 2026 Adam R. Levy Director, Officer (Chief Executive Officer) Open-market sale −7,000 $0.61 $4,270
May 27, 2026 Adam R. Levy Director, Officer (Chief Executive Officer) Open-market sale −3,000 $0.60 $1,800
Dec 24, 2025 Adam R. Levy Director, Officer (Chief Executive Officer) Open-market sale −4,000 $1.57 $6,280
Dec 22, 2025 Adam R. Levy Director, Officer (Chief Executive Officer) Open-market sale −6,000 $1.61 $9,660
Nov 6, 2025 Adam R. Levy Director, Officer (Chief Executive Officer) Open-market sale −4,000 $2.52 $10,080
Oct 3, 2025 Scott Robert Henry Director Open-market sale −7,175 $2.55 $18,296
Oct 3, 2025 Adam R. Levy Director, Officer (Chief Executive Officer) Open-market sale −2,400 $2.55 $6,120
Oct 2, 2025 Scott Robert Henry Director Open-market sale −825 $2.50 $2,063

Organizations in the same sector, closest in location and size first.

Questions about NexGel Inc

Who is the CEO of NexGel Inc?

Adam R. Levy is NexGel Inc's Chief Executive Officer.

How many directors are on NexGel Inc's board?

NexGel Inc's board has 10 directors: Adam R. Levy, Brian Joseph Kieser, David Stefansky, Jerome B. Zeldis, John Nachum Stein, Kevin McClain Harris, Miranda Jayne Toledano, Scott Robert Henry, Steven Ciardiello and Steven Mark Glassman.

Are NexGel Inc insiders buying or selling shares?

Over the last 12 months, NexGel Inc insiders made no open-market purchases and sold $36,730 of shares in 11 sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="nexgel-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.